Latest MPM ONCOLOGY IMPACT MANAGEMENT LP Stock Portfolio
$643Million– No. of Holdings #44
MPM ONCOLOGY IMPACT MANAGEMENT LP Performance:
2024 Q2: -9.52%YTD: 9.63%2023: -9.45%
Performance for 2024 Q2 is -9.52%, and YTD is 9.63%, and 2023 is -9.45%.
About MPM ONCOLOGY IMPACT MANAGEMENT LP and 13F Hedge Fund Stock Holdings
MPM BIOIMPACT LLC is a hedge fund based in CHESTNUT HILL, MA. On 29-Mar-2021, the fund reported that it had an AUM (Regulated Assets under Management) of $1.2 Billions. In it's latest 13F Holdings report, MPM BIOIMPACT LLC reported an equity portfolio of $643.5 Millions as of 30 Jun, 2024.
The top stock holdings of MPM BIOIMPACT LLC are CGEM, INSM, OLMA. The fund has invested 20.7% of it's portfolio in CULLINAN THERAPEUTICS, INC. and 6.4% of portfolio in INSMED INCORPORATED.
The fund managers got completely rid off GERON CORPORATION (GERN), VIRIDIAN THERAPEUTICS INC (VRDN) and AMICUS THERAPEUTICS INC. (FOLD) stocks. They significantly reduced their stock positions in SUTRO BIOPHARMA, INC. (STRO), VIKING THERAPEUTICS INC (VKTX) and AVADEL PHARMACEUTICALS PLC (AVDL). MPM BIOIMPACT LLC opened new stock positions in MIRUM PHARMACEUTICALS INC (MIRM), GUARDANT HEALTH INC (GH) and ALKERMES PLC (ALKS). The fund showed a lot of confidence in some stocks as they added substantially to DISC MEDICINE INC, COMPASS THERAPEUTICS, INC. (CMPX) and ALX ONCOLOGY HOLDINGS INC. (ALXO).
The top stock holdings of MPM BIOIMPACT LLC are CGEM, INSM, OLMA. The fund has invested 20.7% of it's portfolio in CULLINAN THERAPEUTICS, INC. and 6.4% of portfolio in INSMED INCORPORATED.
The fund managers got completely rid off GERON CORPORATION (GERN), VIRIDIAN THERAPEUTICS INC (VRDN) and AMICUS THERAPEUTICS INC. (FOLD) stocks. They significantly reduced their stock positions in SUTRO BIOPHARMA, INC. (STRO), VIKING THERAPEUTICS INC (VKTX) and AVADEL PHARMACEUTICALS PLC (AVDL). MPM BIOIMPACT LLC opened new stock positions in MIRUM PHARMACEUTICALS INC (MIRM), GUARDANT HEALTH INC (GH) and ALKERMES PLC (ALKS). The fund showed a lot of confidence in some stocks as they added substantially to DISC MEDICINE INC, COMPASS THERAPEUTICS, INC. (CMPX) and ALX ONCOLOGY HOLDINGS INC. (ALXO).
MPM ONCOLOGY IMPACT MANAGEMENT LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024
MPM ONCOLOGY IMPACT MANAGEMENT LP Annual Return Estimates Vs S&P 500
Our best estimate is that MPM BIOIMPACT LLC made a return of -9.52% in the last quarter. In trailing 12 months, it's portfolio return was 5.35%.
New Buys
| Ticker | $ Bought |
|---|---|
| mirum pharmaceuticals inc | 16,840,900 |
| guardant health inc | 14,440,000 |
| alkermes plc | 13,437,100 |
| lantheus holdings inc | 12,043,500 |
| hillevax inc | 9,327,930 |
| scholar rock holding corp | 8,565,990 |
| cartesian therapeutics inc | 7,014,390 |
| avidity biosciences inc | 5,106,250 |
New stocks bought by MPM ONCOLOGY IMPACT MANAGEMENT LP
Additions
| Ticker | % Inc. |
|---|---|
| disc medicine inc | 175 |
| compass therapeutics, inc. | 153 |
| alx oncology holdings inc. | 71.93 |
| edgewise therapeutics inc | 67.85 |
| ultragenyx pharmaceutical inc | 54.95 |
| relay therapeutics inc. | 53.18 |
| olema pharmaceuticals, inc. | 35.89 |
| fulcrum therapeutics inc | 27.06 |
Additions to existing portfolio by MPM ONCOLOGY IMPACT MANAGEMENT LP
Reductions
| Ticker | % Reduced |
|---|---|
| sutro biopharma, inc. | -25.71 |
| viking therapeutics inc | -20.69 |
| avadel pharmaceuticals plc | -10.09 |
| zentalis pharmaceuticals, inc. | -4.37 |
MPM ONCOLOGY IMPACT MANAGEMENT LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| geron corporation | -34,569,700 |
| amicus therapeutics inc. | -8,469,470 |
| viridian therapeutics inc | -10,751,300 |
MPM ONCOLOGY IMPACT MANAGEMENT LP got rid off the above stocks
Sector Distribution
MPM BIOIMPACT LLC has about 97.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 97.1 |
| Others | 2.9 |
Market Cap. Distribution
MPM BIOIMPACT LLC has about 9.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 48 |
| MID-CAP | 29.6 |
| LARGE-CAP | 9.3 |
| MICRO-CAP | 9.1 |
| UNALLOCATED | 2.9 |
| NANO-CAP | 1.1 |
Stocks belong to which Index?
About 82.7% of the stocks held by MPM BIOIMPACT LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 82.7 |
| Others | 17.3 |
MPM ONCOLOGY IMPACT MANAGEMENT LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of MPM ONCOLOGY IMPACT MANAGEMENT LP
MPM BIOIMPACT LLC has 44 stocks in it's portfolio. About 53.5% of the portfolio is in top 10 stocks. ZNTL proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for MPM BIOIMPACT LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADAP | adaptimmune therapeutics plc | 0.77 | 5,095,910 | 4,968,510 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 1.41 | 385,990 | 9,055,320 | added | 15.94 | ||
| ALKS | alkermes plc | 2.09 | 557,556 | 13,437,100 | new | |||
| ALLK | allakos | 0.05 | 344,900 | 344,900 | new | |||
| ALXO | alx oncology holdings inc. | 2.04 | 2,180,860 | 13,150,600 | added | 71.93 | ||
| AVDL | avadel pharmaceuticals plc | 1.71 | 783,242 | 11,012,400 | reduced | -10.09 | ||
| AXSM | axsome therapeutics, inc. | 1.66 | 132,312 | 10,651,100 | added | 15.93 | ||
| CGEM | cullinan therapeutics, inc. | 20.73 | 7,648,270 | 133,386,000 | unchanged | 0.00 | ||
| CMPX | compass therapeutics, inc. | 0.78 | 5,005,090 | 5,005,090 | added | 153 | ||
| CRNX | crinetics pharmaceuticals inc. | 3.88 | 557,184 | 24,956,300 | added | 15.94 | ||
| ETNB | 89bio inc | 1.40 | 1,121,740 | 8,985,100 | added | 15.91 | ||
| EWTX | edgewise therapeutics inc | 2.07 | 740,661 | 13,339,300 | added | 67.85 | ||
| FOLD | amicus therapeutics inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FULC | fulcrum therapeutics inc | 1.39 | 1,444,850 | 8,958,080 | added | 27.06 | ||
| GERN | geron corporation | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GH | guardant health inc | 2.24 | 500,000 | 14,440,000 | new | |||
| HLVX | hillevax inc | 1.45 | 645,085 | 9,327,930 | new | |||
| HOWL | werewolf therapeutics, inc. | 0.90 | 2,388,010 | 5,826,750 | unchanged | 0.00 | ||
| INSM | insmed incorporated | 6.41 | 615,391 | 41,231,200 | added | 15.94 | ||
| IOVA | iovance biotherapeutics inc | 2.95 | 2,366,710 | 18,981,000 | added | 7.58 | ||